NR4A1 and breast cancer: Most of the patients diagnosed with primary luminal BC are treated with adjuvant endocrine therapy (ET), such as tamoxifen, anastrozole, letrozole or exemestane, until surgery and/or radiotherapy to block the hormone receptor or to inhibit oestrogen production [3].